IGM Biosciences Retained Earnings (Accumulated Deficit) 2018-2024 | IGMS
IGM Biosciences retained earnings (accumulated deficit) from 2018 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.